000			02108 a2200601 4500
005			20250516150906.0
264		0	_c20130904
008			201309s 0 0 eng d
022			_a1474-4457
024	7		_a10.1016/S1473-3099(13)70093-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aEron, Joseph J
245	0	0	_aEfficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. _h[electronic resource]
260			_bThe Lancet. Infectious diseases _cJul 2013
300			_a587-96 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnti-HIV Agents _xadministration & dosage
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug-Related Side Effects and Adverse Reactions _xepidemiology
650	0	4	_aFemale
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV-1 _xisolation & purification
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPlacebos _xadministration & dosage
650	0	4	_aPyrrolidinones _xadministration & dosage
650	0	4	_aRaltegravir Potassium
650	0	4	_aSalvage Therapy _xadverse effects
650	0	4	_aTreatment Outcome
650	0	4	_aViral Load
700	1		_aCooper, David A
700	1		_aSteigbigel, Roy T
700	1		_aClotet, Bonaventura
700	1		_aGatell, Jose M
700	1		_aKumar, Princy N
700	1		_aRockstroh, Jurgen K
700	1		_aSchechter, Mauro
700	1		_aMarkowitz, Martin
700	1		_aYeni, Patrick
700	1		_aLoutfy, Mona R
700	1		_aLazzarin, Adriano
700	1		_aLennox, Jeffrey L
700	1		_aStrohmaier, Kim M
700	1		_aWan, Hong
700	1		_aBarnard, Richard J O
700	1		_aNguyen, Bach-Yen T
700	1		_aTeppler, Hedy
773	0		_tThe Lancet. Infectious diseases _gvol. 13 _gno. 7 _gp. 587-96
856	4	0	_uhttps://doi.org/10.1016/S1473-3099(13)70093-8 _zAvailable from publisher's website
999			_c22741942 _d22741942